CSL Limited (CSLLY)
(Delayed Data from OTC)
$105.63 USD
+2.27 (2.20%)
Updated Aug 23, 2024 03:51 PM ET
4-Sell of 5 4
D Value C Growth D Momentum D VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
CSLLY 105.63 +2.27(2.20%)
Will CSLLY be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for CSLLY based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for CSLLY
EXEL or CSLLY: Which Is the Better Value Stock Right Now?
GMAB vs. CSLLY: Which Stock Is the Better Value Option?
CSLLY: What are Zacks experts saying now?
Zacks Private Portfolio Services
Are Medical Stocks Lagging Cardinal Health (CAH) This Year?
New Strong Sell Stocks for August 14th
5 Diverse Medical Stocks to Buy for 2023 and Beyond
Other News for CSLLY
CSL Limited: Good Results Overshadowed By Below-Expectations Guidance
Jarden Reaffirms Their Buy Rating on CSL (CMXHF)
RBC Capital Remains a Hold on CSL (CMXHF)
CSL Limited (CSLLY) Q4 2024 Earnings Call Transcript
Wilsons Reaffirms Their Hold Rating on CSL (CMXHF)